by newsworm | Feb 10, 2025 | Pharma
Impax Laboratories LLC and Dr. Reddy’s Laboratories Ltd. have concluded their patent infringement dispute regarding the sale of a generic medication for Parkinson’s disease. The two pharmaceutical companies agreed to dismiss all allegations and... by newsworm | Feb 10, 2025 | Pfizer, Pharma
Pfizer has sold its flexible building at the Imperial Center in Durham, North Carolina, to Lightstone Group for $41.1 million. The property, located at 1219 Shiloh Glenn Drive, is a Class B building spanning 82,054 square feet and sitting on 15.69 acres. The cGMP... by newsworm | Feb 10, 2025 | Fortis, Pharma
Fortis Memorial Research Institute, Gurugram, and Heritage Motoring Club of India joined forces to launch a vintage car rally to create awareness about cancer. The event, held on February 10, 2025, saw over 400 participants, including 45 vintage cars and vintage... by newsworm | Feb 10, 2025 | Lupin, Natco, Pharma
Natco Pharma, in alliance with Lupin, has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Bosentan Tablets for Oral Suspension, 32 mg, a generic equivalent of Actelion Pharmaceuticals’ Tracleer Tablets for Oral Suspension.... by newsworm | Feb 10, 2025 | Glenmark, Pharma
Here is a summary of the content in 400 words: Cosmo Pharmaceuticals N.V. and Glenmark Pharmaceuticals Limited have announced that Glenmark has received approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to market Winlevi, a... by newsworm | Feb 10, 2025 | Lupin, Pharma
Lupin, a global pharmaceutical company, has appointed Abdelaziz Toumi as the Chief Executive Officer (CEO) of its API (Active Pharmaceutical Ingredient) CDMO (Contract Development and Manufacturing Organization) subsidiary. The appointment is effective immediately.... by newsworm | Feb 9, 2025 | Pharma
Dr. Reddy’s Laboratories has received approval from the Central Drugs Standard Control Organization (CDSCO) panel to manufacture and market Esomeprazole gastro-resistant capsules in India. The CDSCO is the apex drug regulatory body in India, responsible for... by newsworm | Feb 9, 2025 | Mankind, Pharma
Mankind Pharma, a leading pharmaceutical company in India, has reported a remarkable 24% growth in revenue for the third quarter (Q3) of the fiscal year 2022-2023 (FY25). This achievement demonstrates the company’s continued growth momentum and expanding market... by newsworm | Feb 9, 2025 | Alkem, Pharma
Alkem Labs has made two strategic acquisitions to reinforce its position in the Indian pharmaceutical market. The company has acquired 100% stake in Adroit Biomed, a skin care-focused pharmaceutical company, for approximately Rs 140 crore (around $18.5 million).... by newsworm | Feb 9, 2025 | Pfizer, Pharma
Jeffrey Todd Legos, the current Chief of Global Medical and Product Development at Novartis, will be joining Pfizer as the new Chief Oncology Officer. This significant leadership change marks a major milestone in the pharmaceutical industry, as Legos will be...